The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma.

Davies, F E; Forsyth, P D; Rawstron, A C; Owen, R G; Pratt, G; Evans, P A; Richards, S J; Drayson, M; Smith, G M; Selby, P J; Child, J A; Morgan, G J

Davies, F E; Forsyth, P D; Rawstron, A C; Owen, R G; Pratt, G; Evans, P A; Richards, S J; Drayson, M; Smith, G M; Selby, P J; Child, J A; Morgan, G J.

Affiliation

Davies FE; Academic Department of Haematology and Oncology, University of Leeds, Leeds LS1, UK.

Br J Haematol ; 112(3): 814-9, 2001 Mar.

Article in En | MEDLINE | ID: mdl-11260088

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cyclophosphamide/therapeutic use; Doxorubicin/therapeutic use; Hematopoietic Stem Cell Transplantation; Melphalan/therapeutic use; Methylprednisolone/therapeutic use; Multiple Myeloma/therapy; Transplantation Conditioning/methods; Vincristine/therapeutic use; Adult; Aged; Bence Jones Protein/urine; Combined Modality Therapy; Disease-Free Survival; Electrophoresis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma/diagnosis; Multiple Myeloma/mortality; Multivariate Analysis; Neoplasm, Residual/diagnosis; Survival Rate; Transplantation, Autologous

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vincristine / Methylprednisolone / Antineoplastic Combined Chemotherapy Protocols / Doxorubicin / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Cyclophosphamide / Melphalan / Multiple Myeloma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2001 Document type: Article

Search on Google

XML

PubMed Links